Cochlear Stock

Cochlear Current Liabilities

The Current Liabilities of Cochlear (COH.AX) as of Sep 8, 2026 is 602.30 M AUD. In the previous year, Current Liabilities was 631.50 M AUD — a change of -4.62% (lower).

Current Liabilities

602.30 MAUD

YoY

-4.62%

Last updated:

Current Liabilities of Cochlear is 2026 602.30 M AUD. Current Liabilities of Cochlear was 2025 631.50 M AUD. It decreases by -4.62% lower compared to the previous year.

The Cochlear Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
287.70 M AUD
Jan 1, 2019
359.50 M AUD
Jan 1, 2020
817.50 M AUD
Jan 1, 2021
402.50 M AUD
Jan 1, 2022
527.60 M AUD
Jan 1, 2023
578.00 M AUD
Jan 1, 2024
631.50 M AUD
Jan 1, 2025
602.30 M AUD
The Cochlear Current Liabilities history
YEARCurrent LiabilitiesYoY
602.30 MAUD-4.62%
631.50 MAUD+9.26%
578.00 MAUD+9.55%
527.60 MAUD+31.08%
402.50 MAUD-50.76%
817.50 MAUD+127.40%
359.50 MAUD+24.96%
287.70 MAUD-17.00%
346.62 MAUD+38.04%
251.10 MAUD-37.74%
403.28 MAUD+137.93%
169.50 MAUD-11.63%
191.80 MAUD-26.77%
261.90 MAUD+17.23%
223.40 MAUD+4.78%
213.20 MAUD+81.91%
117.20 MAUD-6.16%
124.90 MAUD-55.31%
279.50 MAUD+37.41%
203.40 MAUD+8.83%
186.90 MAUD+75.66%
106.40 MAUD+7.04%
99.40 MAUD+19.18%
83.40 MAUD+14.40%
72.90 MAUD+44.64%
50.40 MAUD+4.13%
48.40 MAUD+32.24%
36.60 MAUD+32.61%
27.60 MAUD-5.80%
29.30 MAUD
Access this data via the Eulerpool API

Cochlear Stock analysis

What does Cochlear do? Cochlear Ltd is an Australian-based medical technology company founded in 1981 by engineer Professor Graeme Clark. The company specializes in Cochlear implant systems and other hearing devices. Cochlear Ltd offers accessories, services, and rehabilitation training for individuals with hearing impairments. The company's products are available for both children and adults with varying degrees of hearing loss. Cochlear Ltd operates in different sectors, including Cochlear implant systems, hearing aids, and wireless accessories and streaming systems under the brand names Nucleus® and Baha®. Nucleus® systems utilize a fully implantable cochlear implant and external speech processor to convert sound into electrical signals for interpretation by the brain. Baha® systems are bone-anchored hearing devices for individuals with unilateral to moderate hearing impairments. Cochlear Ltd also provides wireless accessories and streaming systems to connect devices like mobile phones, TVs, and music players to the hearing aids and cochlear implants, improving hearing performance and enhancing social lives. The company has a strong global presence, operating in over 100 countries with headquarters in Australia, multiple production facilities, and research centers. Cochlear Ltd has received numerous awards and recognition for its products and services and is committed to researching and developing new therapies and technologies to improve the lives of individuals with hearing impairments. Cochlear is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cochlear stock

Current Liabilities of Cochlear is 602.30 M AUD in 2026.

Current Liabilities of Cochlear changed from 631.50 M AUD to 602.30 M AUD, representing a -4.62% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Cochlear since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Cochlear historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Cochlear

All Key Metrics — Cochlear